Dr Reddy's reports Q3 profit of Rs 20 crore, revenues at Rs 4,930 crore
DRL said the Q3 results were impacted primarily due the non-recognition of deferred tax assets on impairment.
)
premium
The US business grew by 9 per cent YoY to Rs 1,739 crore
DRL on Friday reported a consolidated net profit of Rs 20 crore in the third quarter against a loss of Rs 569.7 crore in the year-before period.
Topics : Dr Reddy's Laboratories Q3 results